These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 26621002)

  • 1. A systematic review of genetic variants associated with metabolic syndrome in patients with schizophrenia.
    Malan-Müller S; Kilian S; van den Heuvel LL; Bardien S; Asmal L; Warnich L; Emsley RA; Hemmings SM; Seedat S
    Schizophr Res; 2016 Jan; 170(1):1-17. PubMed ID: 26621002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic polymorphisms of HTR2C, LEP and LEPR on metabolic syndromes in patients treated with atypical antipsychotic drugs.
    Puangpetch A; Unaharassamee W; Jiratjintana N; Koomdee N; Sukasem C
    J Pharm Pharmacol; 2018 Apr; 70(4):536-542. PubMed ID: 29441581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Co-shared genetics and possible risk gene pathway partially explain the comorbidity of schizophrenia, major depressive disorder, type 2 diabetes, and metabolic syndrome.
    Postolache TT; Del Bosque-Plata L; Jabbour S; Vergare M; Wu R; Gragnoli C
    Am J Med Genet B Neuropsychiatr Genet; 2019 Apr; 180(3):186-203. PubMed ID: 30729689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between HTR2C polymorphisms and metabolic syndrome in patients with schizophrenia treated with atypical antipsychotics.
    Bai YM; Chen TT; Liou YJ; Hong CJ; Tsai SJ
    Schizophr Res; 2011 Feb; 125(2-3):179-86. PubMed ID: 21185157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic variants impacting metabolic outcomes among people on clozapine: a systematic review and meta-analysis.
    Suetani RJ; Siskind D; Reichhold H; Kisely S
    Psychopharmacology (Berl); 2017 Oct; 234(20):2989-3008. PubMed ID: 28879574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and predictors of metabolic syndrome in patients with schizophrenia and healthy controls: A study in rural South Indian population.
    Rawat VS; Ganesh S; Bijjal S; Shanivaram Reddy K; Agarwal V; Devi R; Kumar CN; Christopher R; Thirthalli J
    Schizophr Res; 2018 Feb; 192():102-107. PubMed ID: 28454923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of genetic loci that overlap between schizophrenia and metabolic syndrome.
    Lv H; Li J; Gao K; Zeng L; Xue R; Liu X; Zhou C; Yue W; Yu H
    Psychiatry Res; 2022 Dec; 318():114947. PubMed ID: 36399892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relationship between cognitive impairment in schizophrenia and metabolic syndrome: a systematic review and meta-analysis.
    Bora E; Akdede BB; Alptekin K
    Psychol Med; 2017 Apr; 47(6):1030-1040. PubMed ID: 28032535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymorphisms of INSIG2, MC4R, and LEP are associated with obesity- and metabolic-related traits in schizophrenic patients.
    Kuo PH; Kao CF; Chen PY; Chen CH; Tsai YS; Lu ML; Huang MC
    J Clin Psychopharmacol; 2011 Dec; 31(6):705-11. PubMed ID: 22020349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic variants and the metabolic syndrome: a systematic review.
    Povel CM; Boer JM; Reiling E; Feskens EJ
    Obes Rev; 2011 Nov; 12(11):952-67. PubMed ID: 21749608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene Polymorphisms of Hormonal Regulators of Metabolism in Patients with Schizophrenia with Metabolic Syndrome.
    Boiko AS; Pozhidaev IV; Paderina DZ; Mednova IA; Goncharova AA; Fedorenko OY; Kornetova EG; Semke AV; Bokhan NA; Loonen AJM; Ivanova SA
    Genes (Basel); 2022 May; 13(5):. PubMed ID: 35627229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of metabolic syndrome and inflammation with neurocognition in patients with schizophrenia.
    Boyer L; Richieri R; Dassa D; Boucekine M; Fernandez J; Vaillant F; Padovani R; Auquier P; Lancon C
    Psychiatry Res; 2013 Dec; 210(2):381-6. PubMed ID: 23850204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic syndrome in schizophrenia.
    Malhotra N; Grover S; Chakrabarti S; Kulhara P
    Indian J Psychol Med; 2013 Jul; 35(3):227-40. PubMed ID: 24249923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of 5-HT2C receptor and leptin gene polymorphisms, smoking and drug treatment on metabolic disturbances in patients with schizophrenia.
    Yevtushenko OO; Cooper SJ; O'Neill R; Doherty JK; Woodside JV; Reynolds GP
    Br J Psychiatry; 2008 Jun; 192(6):424-8. PubMed ID: 18515891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between C-reactive protein and homocysteine with the subcomponents of metabolic syndrome in stable patients with bipolar disorder and schizophrenia.
    Vuksan-Cusa B; Sagud M; Jakovljevic M; Peles AM; Jaksic N; Mihaljevic S; Zivkovic M; Mikulic SK; Jevtovic S
    Nord J Psychiatry; 2013 Oct; 67(5):320-5. PubMed ID: 23228159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Metabolic syndrome and bipolar disorder: Is sleep the missing link?].
    Brochard H; Boudebesse C; Henry C; Godin O; Leboyer M; Étain B
    Encephale; 2016 Dec; 42(6):562-567. PubMed ID: 27663044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between SCAP and SREBF1 gene polymorphisms and metabolic syndrome in schizophrenia patients treated with atypical antipsychotics.
    Yang L; Chen J; Li Y; Wang Y; Liang S; Shi Y; Shi S; Xu Y
    World J Biol Psychiatry; 2016 Sep; 17(6):467-74. PubMed ID: 26982812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical, Biochemical and Genetic Variables Associated With Metabolic Syndrome in Patients With Schizophrenia Spectrum Disorders Using Second-Generation Antipsychotics: A Systematic Review.
    Sneller MH; de Boer N; Everaars S; Schuurmans M; Guloksuz S; Cahn W; Luykx JJ
    Front Psychiatry; 2021; 12():625935. PubMed ID: 33868046
    [No Abstract]   [Full Text] [Related]  

  • 19. [Drawing up guidelines for the attendance of physical health of patients with severe mental illness].
    Saravane D; Feve B; Frances Y; Corruble E; Lancon C; Chanson P; Maison P; Terra JL; Azorin JM;
    Encephale; 2009 Sep; 35(4):330-9. PubMed ID: 19748369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of expression of selenoprotein P in mRNA and protein levels with metabolic syndrome in subjects with cardiovascular disease: Results of the Selenegene study.
    Gharipour M; Sadeghi M; Salehi M; Behmanesh M; Khosravi E; Dianatkhah M; Haghjoo Javanmard S; Razavi R; Gharipour A
    J Gene Med; 2017 Mar; 19(3):. PubMed ID: 28190280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.